Levomed

Levodopa, the active ingredient in Levomed, is a dopamine precursor presented as an oral tablet for oral use. It is combined with carbidopa, a DOPA decarboxylase inhibitor, to treat Parkinson's disease and related Parkinsonian syndromes in adults.

GNH USA supplies Levomed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levodopa/Carbidopa is used in the management of Parkinsonian disorders, targeting dopaminergic deficiency.

- Parkinson's disease: improves motor symptoms such as bradykinesia, rigidity and tremor. - Parkinsonian syndrome: alleviates secondary Parkinsonism caused by drugs or other conditions. - Resting tremor: reduces frequency and amplitude of tremor associated with dopaminergic loss.

Levodopa/Carbidopa may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: gastrointestinal upset occurring early in therapy. - Dizziness: often related to orthostatic hypotension. - Headache: mild to moderate intensity. - Insomnia: difficulty initiating or maintaining sleep. - Dry mouth: reduced salivation. - Orthostatic hypotension: drop in blood pressure upon standing.

Serious or Rare Side Effects: - Dyskinesia: involuntary, erratic movements, especially with long‑term use. - Psychosis: hallucinations or delusional thinking. - Severe hypotension: may lead to fainting. - Cardiac arrhythmias: irregular heart rhythms in susceptible patients. - Neuroleptic malignant syndrome: rare but life‑threatening reaction. - Allergic reactions: rash, pruritus, or anaphylaxis.

When prescribing Levomed, clinicians should consider several safety measures.

- Dose titration: start low and increase gradually to minimize side effects. - Blood pressure monitoring: watch for orthostatic hypotension, especially in the elderly. - Psychiatric assessment: monitor for hallucinations, confusion, or mood changes. - Concomitant drugs: avoid abrupt discontinuation of dopaminergic agents. - Renal/hepatic impairment: adjust therapy based on organ function. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Levodopa/Carbidopa interacts with several medication classes that may alter its efficacy or safety.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - Antipsychotics (e.g., haloperidol): antagonize dopaminergic effect, reducing therapeutic benefit. - Antihypertensive agents: additive hypotensive effect may cause severe blood pressure drops.

Moderate Interactions (Monitor Closely): - Iron supplements and antacids: decrease levodopa absorption; separate dosing by at least 2 hours. - Selective serotonin reuptake inhibitors: may increase risk of serotonin syndrome. - Other dopaminergic drugs (e.g., dopamine agonists): monitor for excessive dyskinesia. - High‑protein meals: compete for transport across the blood‑brain barrier, potentially reducing efficacy.